ENTRY       hsa05167                    Pathway
NAME        Kaposi sarcoma-associated herpesvirus infection - Homo sapiens (human)
DESCRIPTION Kaposi sarcoma-associated herpesvirus (KSHV), also known as human herpesvirus 8 (HHV-8), is the most recently identified human tumor virus, and is associated with the pathogenesis of Kaposi's sarcoma (KS), primary effusion lymphoma (PEL), and Multicentric Castleman's disease (MCD). Like all other herpesviruses, KSHV displays two modes of life cycle, latency and lytic replication, which are characterized by the patterns of viral gene expression. Genes expressed in latency (LANA, v-cyclin, v-FLIP, Kaposins A, B and C and viral miRNAs) are mainly thought to facilitate the establishment of life long latency in its host and survival against the host innate, and adaptive immune surveillance mechanisms. Among the viral proteins shown to be expressed during lytic replication are potent signaling molecules such as vGPCR, vIL6, vIRFs, vCCLs, K1 and K15, which have been implicated experimentally in the angiogenic and inflammatory phenotype observed in KS lesions. Several of these latent viral and lytic proteins are known to transform host cells, linking KSHV with the development of severe human malignancies.
CLASS       Human Diseases; Infectious disease: viral
PATHWAY_MAP hsa05167  Kaposi sarcoma-associated herpesvirus infection
NETWORK     nt06164  Kaposi sarcoma-associated herpesvirus (KSHV)
            nt06210  ERK signaling (cancer)
            nt06211  Other MAPK signaling (cancer)
            nt06214  PI3K signaling (cancer)
            nt06215  WNT signaling (cancer)
            nt06219  JAK-STAT signaling (cancer)
            nt06220  Calcium signaling (cancer)
            nt06222  IFN signaling (cancer)
            nt06223  TNF signaling (cancer)
            nt06224  CXCR signaling (cancer)
            nt06229  MHC presentation (cancer)
            nt06230  Cell cycle (cancer)
            nt06231  Apoptosis (cancer)
            nt06505  WNT signaling
            nt06513  Complement cascade
            nt06516  TNF signaling
            nt06517  TLR signaling
            nt06518  JAK-STAT signaling
            nt06524  Apoptosis
            nt06532  Autophagy
            nt06533  Chemokine signaling
  ELEMENT   N00157  KSHV vGPCR to GNB/G-ERK signaling pathway
            N00158  KSHV vGPCR to GNB/G-PI3K-AKT signaling pathway
            N00159  KSHV K1 to PI3K signaling pathway
            N00160  KSHV K1 to RAS-ERK signaling pathway
            N00161  KSHV vIRF1/2 to TLR3-IRF3 signaling pathway
            N00162  KSHV vIRF3 to TLR3-IRF7 signaling pathway
            N00163  KSHV KIE1/2 to TLR3-IRF7 signaling pathway
            N00164  KSHV vBCL2 to crosstalk between extrinsic and intrinsic apoptotic pathways
            N00165  KSHV vIAP to crosstalk between extrinsic and intrinsic apoptotic pathways
            N00166  KSHV vFLIP to crosstalk between extrinsic and intrinsic apoptotic pathways
            N00167  KSHV vIRF1/3 to p21-cell cycle G1/S
            N00168  KSHV vCyclin to cell cycle G1/S
            N00169  KSHV LANA to p21-cell cycle G1/S
            N00170  KSHV LANA to cell cycle G1/S
            N00171  KSHV vFLIP to NFKB signaling pathway
            N00172  KSHV K15 to PLCG-calcineurin signaling pathway
            N00173  KSHV K15 to TNF-NFKB signaling pathway
            N00174  KSHV vFLIP to TNF-NFKB signaling pathway
            N00175  KSHV LANA to Wnt signaling pathway
            N00176  KSHV vFLIP to autophagy-vesicle elongation
            N00177  KSHV vBCL2 to autophagy-vesicle nucleation
            N00178  KSHV vGPCR to GNB/G-PI3K-JNK signaling pathway
            N00179  KSHV K1 to PI3K-NFKB signaling pathway
            N00180  KSHV K1 to PLCG-calcineurin signaling pathway
            N00181  KSHV vIL-6 to Jak-STAT signaling pathway
            N00184  KSHV MIR1/2 to antigen processing and presentation by MHC class I molecules
            N00185  KSHV MIR2 to cell surface molecule-endocytosis
            N00187  KSHV Kaposin B to p38 signaling pathway
            N00189  KSHV K15 to JNK signaling pathway
            N00212  KSHV vCCL2 to CCR signaling pathway
            N00213  KSHV Kaposin to alternative pathway of complement cascade
            N00261  KSHV vIRF2 to IFN signaling pathway
            N00462  KSHV vCCL1/2/3 to CCR signaling pathway
            N01527  KSHV Kaposin to classical/Lectin pathway of complement cascade, C4b breakdown
            N01528  KSHV Kaposin to alternative pathway of complement cascade, C3b breakdown
DISEASE     H00041  Kaposi sarcoma
DRUG        D02745  Interferon alfa-2b (USAN)
ORGANISM    Homo sapiens (human) [GN:hsa]
GENE        10000  AKT3; AKT serine/threonine kinase 3 [KO:K04456] [EC:2.7.11.1]
            100507436  MICA; MHC class I polypeptide-related sequence A [KO:K07985]
            1019  CDK4; cyclin dependent kinase 4 [KO:K02089] [EC:2.7.11.22]
            1021  CDK6; cyclin dependent kinase 6 [KO:K02091] [EC:2.7.11.22]
            1026  CDKN1A; cyclin dependent kinase inhibitor 1A [KO:K06625]
            10379  IRF9; interferon regulatory factor 9 [KO:K04693]
            10681  GNB5; G protein subunit beta 5 [KO:K04539]
            110117499  P3R3URF-PIK3R3; P3R3URF-PIK3R3 readthrough [KO:K02649]
            1147  CHUK; component of inhibitor of nuclear factor kappa B kinase complex [KO:K04467] [EC:2.7.11.10]
            1230  CCR1; C-C motif chemokine receptor 1 [KO:K04176]
            1232  CCR3; C-C motif chemokine receptor 3 [KO:K04178]
            1233  CCR4; C-C motif chemokine receptor 4 [KO:K04179]
            1234  CCR5; C-C motif chemokine receptor 5 [KO:K04180]
            1237  CCR8; C-C motif chemokine receptor 8 [KO:K04183]
            131450  CD200R1; CD200 receptor 1 [KO:K21668]
            1385  CREB1; cAMP responsive element binding protein 1 [KO:K05870]
            1387  CREBBP; CREB binding protein [KO:K04498] [EC:2.3.1.48]
            1432  MAPK14; mitogen-activated protein kinase 14 [KO:K04441] [EC:2.7.11.24]
            1437  CSF2; colony stimulating factor 2 [KO:K05427]
            146850  PIK3R6; phosphoinositide-3-kinase regulatory subunit 6 [KO:K21290]
            148022  TICAM1; TIR domain containing adaptor molecule 1 [KO:K05842]
            1499  CTNNB1; catenin beta 1 [KO:K02105]
            163688  CALML6; calmodulin like 6 [KO:K02183]
            1827  RCAN1; regulator of calcineurin 1 [KO:K17901]
            1869  E2F1; E2F transcription factor 1 [KO:K17454]
            1870  E2F2; E2F transcription factor 2 [KO:K09389]
            1871  E2F3; E2F transcription factor 3 [KO:K06620]
            2033  EP300; E1A binding protein p300 [KO:K04498] [EC:2.3.1.48]
            207  AKT1; AKT serine/threonine kinase 1 [KO:K04456] [EC:2.7.11.1]
            208  AKT2; AKT serine/threonine kinase 2 [KO:K04456] [EC:2.7.11.1]
            2247  FGF2; fibroblast growth factor 2 [KO:K18497]
            22863  ATG14; autophagy related 14 [KO:K17889]
            2353  FOS; Fos proto-oncogene, AP-1 transcription factor subunit [KO:K04379]
            23533  PIK3R5; phosphoinositide-3-kinase regulatory subunit 5 [KO:K21290]
            2475  MTOR; mechanistic target of rapamycin kinase [KO:K07203] [EC:2.7.11.1]
            2782  GNB1; G protein subunit beta 1 [KO:K04536]
            2783  GNB2; G protein subunit beta 2 [KO:K04537]
            2784  GNB3; G protein subunit beta 3 [KO:K07825]
            2785  GNG3; G protein subunit gamma 3 [KO:K04540]
            2786  GNG4; G protein subunit gamma 4 [KO:K04541]
            2787  GNG5; G protein subunit gamma 5 [KO:K04542]
            2788  GNG7; G protein subunit gamma 7 [KO:K04543]
            2790  GNG10; G protein subunit gamma 10 [KO:K04545]
            2791  GNG11; G protein subunit gamma 11 [KO:K04546]
            2792  GNGT1; G protein subunit gamma transducin 1 [KO:K04548]
            2793  GNGT2; G protein subunit gamma transducin 2 [KO:K04549]
            285  ANGPT2; angiopoietin 2 [KO:K05466]
            29110  TBK1; TANK binding kinase 1 [KO:K05410] [EC:2.7.11.10]
            2919  CXCL1; C-X-C motif chemokine ligand 1 [KO:K05505]
            2920  CXCL2; C-X-C motif chemokine ligand 2 [KO:K05505]
            2921  CXCL3; C-X-C motif chemokine ligand 3 [KO:K05505]
            2932  GSK3B; glycogen synthase kinase 3 beta [KO:K03083] [EC:2.7.11.26]
            3055  HCK; HCK proto-oncogene, Src family tyrosine kinase [KO:K08893] [EC:2.7.10.2]
            3091  HIF1A; hypoxia inducible factor 1 subunit alpha [KO:K08268]
            3105  HLA-A; major histocompatibility complex, class I, A [KO:K06751]
            3106  HLA-B; major histocompatibility complex, class I, B [KO:K06751]
            3107  HLA-C; major histocompatibility complex, class I, C [KO:K06751]
            3133  HLA-E; major histocompatibility complex, class I, E [KO:K06751]
            3134  HLA-F; major histocompatibility complex, class I, F [KO:K06751]
            3135  HLA-G; major histocompatibility complex, class I, G [KO:K06751]
            3265  HRAS; HRas proto-oncogene, GTPase [KO:K02833]
            3383  ICAM1; intercellular adhesion molecule 1 [KO:K06490]
            3439  IFNA1; interferon alpha 1 [KO:K05414]
            3440  IFNA2; interferon alpha 2 [KO:K05414]
            3441  IFNA4; interferon alpha 4 [KO:K05414]
            3442  IFNA5; interferon alpha 5 [KO:K05414]
            3443  IFNA6; interferon alpha 6 [KO:K05414]
            3444  IFNA7; interferon alpha 7 [KO:K05414]
            3445  IFNA8; interferon alpha 8 [KO:K05414]
            3446  IFNA10; interferon alpha 10 [KO:K05414]
            3447  IFNA13; interferon alpha 13 [KO:K05414]
            3448  IFNA14; interferon alpha 14 [KO:K05414]
            344807  CD200R1L; CD200 receptor 1 like [KO:K21668]
            3449  IFNA16; interferon alpha 16 [KO:K05414]
            3451  IFNA17; interferon alpha 17 [KO:K05414]
            3452  IFNA21; interferon alpha 21 [KO:K05414]
            3454  IFNAR1; interferon alpha and beta receptor subunit 1 [KO:K05130]
            3455  IFNAR2; interferon alpha and beta receptor subunit 2 [KO:K05131]
            3456  IFNB1; interferon beta 1 [KO:K05415]
            3459  IFNGR1; interferon gamma receptor 1 [KO:K05132]
            355  FAS; Fas cell surface death receptor [KO:K04390]
            3551  IKBKB; inhibitor of nuclear factor kappa B kinase subunit beta [KO:K07209] [EC:2.7.11.10]
            3569  IL6; interleukin 6 [KO:K05405]
            3572  IL6ST; interleukin 6 cytokine family signal transducer [KO:K05060]
            3576  CXCL8; C-X-C motif chemokine ligand 8 [KO:K10030]
            3661  IRF3; interferon regulatory factor 3 [KO:K05411]
            3665  IRF7; interferon regulatory factor 7 [KO:K09447]
            3708  ITPR1; inositol 1,4,5-trisphosphate receptor type 1 [KO:K04958]
            3709  ITPR2; inositol 1,4,5-trisphosphate receptor type 2 [KO:K04959]
            3710  ITPR3; inositol 1,4,5-trisphosphate receptor type 3 [KO:K04960]
            3716  JAK1; Janus kinase 1 [KO:K11217] [EC:2.7.10.2]
            3717  JAK2; Janus kinase 2 [KO:K04447] [EC:2.7.10.2]
            3725  JUN; Jun proto-oncogene, AP-1 transcription factor subunit [KO:K04448]
            3845  KRAS; KRAS proto-oncogene, GTPase [KO:K07827]
            392288  MAP1LC3BP1; microtubule associated protein 1 light chain 3 beta pseudogene 1 [KO:K10435]
            4067  LYN; LYN proto-oncogene, Src family tyrosine kinase [KO:K05854] [EC:2.7.10.2]
            4277  MICB; MHC class I polypeptide-related sequence B [KO:K07985]
            440738  MAP1LC3C; microtubule associated protein 1 light chain 3 gamma [KO:K10435]
            441925  BECN2; beclin 2 [KO:K08334]
            4609  MYC; MYC proto-oncogene, bHLH transcription factor [KO:K04377]
            4772  NFATC1; nuclear factor of activated T cells 1 [KO:K04446]
            4773  NFATC2; nuclear factor of activated T cells 2 [KO:K17332]
            4775  NFATC3; nuclear factor of activated T cells 3 [KO:K17333]
            4776  NFATC4; nuclear factor of activated T cells 4 [KO:K17334]
            4790  NFKB1; nuclear factor kappa B subunit 1 [KO:K02580]
            4792  NFKBIA; NFKB inhibitor alpha [KO:K04734]
            4893  NRAS; NRAS proto-oncogene, GTPase [KO:K07828]
            51176  LEF1; lymphoid enhancer binding factor 1 [KO:K04492]
            5155  PDGFB; platelet derived growth factor subunit B [KO:K17386]
            51764  GNG13; G protein subunit gamma 13 [KO:K04547]
            51806  CALML5; calmodulin like 5 [KO:K02183]
            5289  PIK3C3; phosphatidylinositol 3-kinase catalytic subunit type 3 [KO:K00914] [EC:2.7.1.137]
            5290  PIK3CA; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha [KO:K00922] [EC:2.7.1.153]
            5291  PIK3CB; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta [KO:K00922] [EC:2.7.1.153]
            5293  PIK3CD; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta [KO:K00922] [EC:2.7.1.153]
            5294  PIK3CG; phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma [KO:K21289] [EC:2.7.1.153]
            5295  PIK3R1; phosphoinositide-3-kinase regulatory subunit 1 [KO:K02649]
            5296  PIK3R2; phosphoinositide-3-kinase regulatory subunit 2 [KO:K02649]
            5335  PLCG1; phospholipase C gamma 1 [KO:K01116] [EC:3.1.4.11]
            5336  PLCG2; phospholipase C gamma 2 [KO:K05859] [EC:3.1.4.11]
            54205  CYCS; cytochrome c, somatic [KO:K08738]
            54331  GNG2; G protein subunit gamma 2 [KO:K07826]
            5530  PPP3CA; protein phosphatase 3 catalytic subunit alpha [KO:K04348] [EC:3.1.3.16]
            5532  PPP3CB; protein phosphatase 3 catalytic subunit beta [KO:K04348] [EC:3.1.3.16]
            5533  PPP3CC; protein phosphatase 3 catalytic subunit gamma [KO:K04348] [EC:3.1.3.16]
            5534  PPP3R1; protein phosphatase 3 regulatory subunit B, alpha [KO:K06268]
            5535  PPP3R2; protein phosphatase 3 regulatory subunit B, beta [KO:K06268]
            5594  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]
            5595  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]
            55970  GNG12; G protein subunit gamma 12 [KO:K04347]
            5599  MAPK8; mitogen-activated protein kinase 8 [KO:K04440] [EC:2.7.11.24]
            5600  MAPK11; mitogen-activated protein kinase 11 [KO:K04441] [EC:2.7.11.24]
            5601  MAPK9; mitogen-activated protein kinase 9 [KO:K04440] [EC:2.7.11.24]
            5602  MAPK10; mitogen-activated protein kinase 10 [KO:K04440] [EC:2.7.11.24]
            5603  MAPK13; mitogen-activated protein kinase 13 [KO:K04441] [EC:2.7.11.24]
            5604  MAP2K1; mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]
            5605  MAP2K2; mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]
            5608  MAP2K6; mitogen-activated protein kinase kinase 6 [KO:K04433] [EC:2.7.12.2]
            5609  MAP2K7; mitogen-activated protein kinase kinase 7 [KO:K04431] [EC:2.7.12.2]
            5610  EIF2AK2; eukaryotic translation initiation factor 2 alpha kinase 2 [KO:K16195] [EC:2.7.11.1]
            5743  PTGS2; prostaglandin-endoperoxide synthase 2 [KO:K11987] [EC:1.14.99.1]
            57580  PREX1; phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 1 [KO:K12365]
            578  BAK1; BCL2 antagonist/killer 1 [KO:K14021]
            581  BAX; BCL2 associated X, apoptosis regulator [KO:K02159]
            5879  RAC1; Rac family small GTPase 1 [KO:K04392]
            5894  RAF1; Raf-1 proto-oncogene, serine/threonine kinase [KO:K04366] [EC:2.7.11.1]
            5925  RB1; RB transcriptional corepressor 1 [KO:K06618]
            59345  GNB4; G protein subunit beta 4 [KO:K04538]
            595  CCND1; cyclin D1 [KO:K04503]
            5970  RELA; RELA proto-oncogene, NF-kB subunit [KO:K04735]
            6233  RPS27A; ribosomal protein S27a [KO:K02977]
            6300  MAPK12; mitogen-activated protein kinase 12 [KO:K04441] [EC:2.7.11.24]
            637  BID; BH3 interacting domain death agonist [KO:K04726]
            6416  MAP2K4; mitogen-activated protein kinase kinase 4 [KO:K04430] [EC:2.7.12.2]
            643246  MAP1LC3B2; microtubule associated protein 1 light chain 3 beta 2 [KO:K10435]
            64422  ATG3; autophagy related 3 [KO:K08343]
            6714  SRC; SRC proto-oncogene, non-receptor tyrosine kinase [KO:K05704] [EC:2.7.10.2]
            6772  STAT1; signal transducer and activator of transcription 1 [KO:K11220]
            6773  STAT2; signal transducer and activator of transcription 2 [KO:K11221]
            6774  STAT3; signal transducer and activator of transcription 3 [KO:K04692]
            6850  SYK; spleen associated tyrosine kinase [KO:K05855] [EC:2.7.10.2]
            6932  TCF7; transcription factor 7 [KO:K02620]
            6934  TCF7L2; transcription factor 7 like 2 [KO:K04491]
            7098  TLR3; toll like receptor 3 [KO:K05401]
            7132  TNFRSF1A; TNF receptor superfamily member 1A [KO:K03158]
            7157  TP53; tumor protein p53 [KO:K04451]
            718  C3; complement C3 [KO:K03990]
            7186  TRAF2; TNF receptor associated factor 2 [KO:K03173] [EC:2.3.2.27]
            7187  TRAF3; TNF receptor associated factor 3 [KO:K03174]
            7297  TYK2; tyrosine kinase 2 [KO:K11219] [EC:2.7.10.2]
            7311  UBA52; ubiquitin A-52 residue ribosomal protein fusion product 1 [KO:K02927]
            7314  UBB; ubiquitin B [KO:K04551]
            7316  UBC; ubiquitin C [KO:K08770]
            7422  VEGFA; vascular endothelial growth factor A [KO:K05448]
            7538  ZFP36; ZFP36 ring finger protein [KO:K15308]
            801  CALM1; calmodulin 1 [KO:K02183]
            805  CALM2; calmodulin 2 [KO:K02183]
            808  CALM3; calmodulin 3 [KO:K02183]
            810  CALML3; calmodulin like 3 [KO:K02183]
            81631  MAP1LC3B; microtubule associated protein 1 light chain 3 beta [KO:K10435]
            83439  TCF7L1; transcription factor 7 like 1 [KO:K04490]
            836  CASP3; caspase 3 [KO:K02187] [EC:3.4.22.56]
            841  CASP8; caspase 8 [KO:K04398] [EC:3.4.22.61]
            842  CASP9; caspase 9 [KO:K04399] [EC:3.4.22.62]
            84557  MAP1LC3A; microtubule associated protein 1 light chain 3 alpha [KO:K10435]
            8503  PIK3R3; phosphoinositide-3-kinase regulatory subunit 3 [KO:K02649]
            8517  IKBKG; inhibitor of nuclear factor kappa B kinase regulatory subunit gamma [KO:K07210]
            8678  BECN1; beclin 1 [KO:K08334]
            8717  TRADD; TNFRSF1A associated via death domain [KO:K03171]
            8772  FADD; Fas associated via death domain [KO:K02373]
            91860  CALML4; calmodulin like 4 [KO:K02183]
            9261  MAPKAPK2; MAPK activated protein kinase 2 [KO:K04443] [EC:2.7.11.1]
            942  CD86; CD86 molecule [KO:K05413]
            94235  GNG8; G protein subunit gamma 8 [KO:K04544]
            9641  IKBKE; inhibitor of nuclear factor kappa B kinase subunit epsilon [KO:K07211] [EC:2.7.11.10]
            9976  CLEC2B; C-type lectin domain family 2 member B [KO:K10071]
COMPOUND    C00076  Calcium cation
            C00165  Diacylglycerol
            C00350  Phosphatidylethanolamine
            C01245  D-myo-Inositol 1,4,5-trisphosphate
            C05981  Phosphatidylinositol-3,4,5-trisphosphate
REFERENCE   PMID:22403573
  AUTHORS   Lee HR, Brulois K, Wong L, Jung JU
  TITLE     Modulation of Immune System by Kaposi's Sarcoma-Associated Herpesvirus: Lessons from Viral Evasion Strategies.
  JOURNAL   Front Microbiol 3:44 (2012)
            DOI:10.3389/fmicb.2012.00044
REFERENCE   PMID:18948197
  AUTHORS   Liang C, Lee JS, Jung JU
  TITLE     Immune evasion in Kaposi's sarcoma-associated herpes virus associated oncogenesis.
  JOURNAL   Semin Cancer Biol 18:423-36 (2008)
            DOI:10.1016/j.semcancer.2008.09.003
REFERENCE   PMID:21040832
  AUTHORS   Cai Q, Verma SC, Lu J, Robertson ES
  TITLE     Molecular biology of Kaposi's sarcoma-associated herpesvirus and related oncogenesis.
  JOURNAL   Adv Virus Res 78:87-142 (2010)
            DOI:10.1016/B978-0-12-385032-4.00003-3
REFERENCE   PMID:16760382
  AUTHORS   Rezaee SA, Cunningham C, Davison AJ, Blackbourn DJ
  TITLE     Kaposi's sarcoma-associated herpesvirus immune modulation: an overview.
  JOURNAL   J Gen Virol 87:1781-804 (2006)
            DOI:10.1099/vir.0.81919-0
REFERENCE   PMID:19230674
  AUTHORS   Areste C, Blackbourn DJ
  TITLE     Modulation of the immune system by Kaposi's sarcoma-associated herpesvirus.
  JOURNAL   Trends Microbiol 17:119-29 (2009)
            DOI:10.1016/j.tim.2008.12.001
REFERENCE   PMID:16905191
  AUTHORS   Mark L, Spiller OB, Villoutreix BO, Blom AM
  TITLE     Kaposi's sarcoma-associated herpes virus complement control protein: KCP--complement inhibition and more.
  JOURNAL   Mol Immunol 44:11-22 (2007)
            DOI:10.1016/j.molimm.2006.06.018
REFERENCE   PMID:11500830
  AUTHORS   Weber KS, Grone HJ, Rocken M, Klier C, Gu S, Wank R, Proudfoot AE, Nelson PJ, Weber C
  TITLE     Selective recruitment of Th2-type cells and evasion from a cytotoxic immune response mediated by viral macrophage inhibitory protein-II.
  JOURNAL   Eur J Immunol 31:2458-66 (2001)
            DOI:10.1002/1521-4141(200108)31:8<2458::AID-IMMU2458>3.0.CO;2-L
REFERENCE   PMID:10666184
  AUTHORS   Stine JT, Wood C, Hill M, Epp A, Raport CJ, Schweickart VL, Endo Y, Sasaki T, Simmons G, Boshoff C, Clapham P, Chang Y, Moore P, Gray PW, Chantry D
  TITLE     KSHV-encoded CC chemokine vMIP-III is a CCR4 agonist, stimulates angiogenesis, and selectively chemoattracts TH2 cells.
  JOURNAL   Blood 95:1151-7 (2000)
REFERENCE   PMID:26431609
  AUTHORS   Schulz TF, Cesarman E
  TITLE     Kaposi Sarcoma-associated Herpesvirus: mechanisms of oncogenesis.
  JOURNAL   Curr Opin Virol 14:116-28 (2015)
            DOI:10.1016/j.coviro.2015.08.016
REFERENCE   PMID:10377196
  AUTHORS   Endres MJ, Garlisi CG, Xiao H, Shan L, Hedrick JA
  TITLE     The Kaposi's sarcoma-related herpesvirus (KSHV)-encoded chemokine vMIP-I is a specific agonist for the CC chemokine receptor (CCR)8.
  JOURNAL   J Exp Med 189:1993-8 (1999)
            DOI:10.1084/jem.189.12.1993
REFERENCE   PMID:18434408
  AUTHORS   Choi YB, Nicholas J
  TITLE     Autocrine and paracrine promotion of cell survival and virus replication by human herpesvirus 8 chemokines.
  JOURNAL   J Virol 82:6501-13 (2008)
            DOI:10.1128/JVI.02396-07
REFERENCE   PMID:15692053
  AUTHORS   McCormick C, Ganem D
  TITLE     The kaposin B protein of KSHV activates the p38/MK2 pathway and stabilizes cytokine mRNAs.
  JOURNAL   Science 307:739-41 (2005)
            DOI:10.1126/science.1105779
REFERENCE   PMID:15967719
  AUTHORS   Wang HW, Boshoff C
  TITLE     Linking Kaposi virus to cancer-associated cytokines.
  JOURNAL   Trends Mol Med 11:309-12 (2005)
            DOI:10.1016/j.molmed.2005.06.002
REFERENCE   PMID:16828973
  AUTHORS   Jarviluoma A, Ojala PM
  TITLE     Cell signaling pathways engaged by KSHV.
  JOURNAL   Biochim Biophys Acta 1766:140-58 (2006)
            DOI:10.1016/j.bbcan.2006.05.001
REFERENCE   PMID:12032073
  AUTHORS   Wang HW, Sharp TV, Koumi A, Koentges G, Boshoff C
  TITLE     Characterization of an anti-apoptotic glycoprotein encoded by Kaposi's sarcoma-associated herpesvirus which resembles a spliced variant of human survivin.
  JOURNAL   EMBO J 21:2602-15 (2002)
            DOI:10.1093/emboj/21.11.2602
REFERENCE   PMID:10510092
  AUTHORS   Djerbi M, Screpanti V, Catrina AI, Bogen B, Biberfeld P, Grandien A
  TITLE     The inhibitor of death receptor signaling, FLICE-inhibitory protein defines a new class of tumor progression factors.
  JOURNAL   J Exp Med 190:1025-32 (1999)
            DOI:10.1084/jem.190.7.1025
REFERENCE   PMID:10523854
  AUTHORS   Chaudhary PM, Jasmin A, Eby MT, Hood L
  TITLE     Modulation of the NF-kappa B pathway by virally encoded death effector domains-containing proteins.
  JOURNAL   Oncogene 18:5738-46 (1999)
            DOI:10.1038/sj.onc.1202976
REFERENCE   PMID:12890756
  AUTHORS   Field N, Low W, Daniels M, Howell S, Daviet L, Boshoff C, Collins M
  TITLE     KSHV vFLIP binds to IKK-gamma to activate IKK.
  JOURNAL   J Cell Sci 116:3721-8 (2003)
            DOI:10.1242/jcs.00691
REFERENCE   PMID:20865011
  AUTHORS   Mesri EA, Cesarman E, Boshoff C
  TITLE     Kaposi's sarcoma and its associated herpesvirus.
  JOURNAL   Nat Rev Cancer 10:707-19 (2010)
            DOI:10.1038/nrc2888
REFERENCE   PMID:10799607
  AUTHORS   Ishido S, Wang C, Lee BS, Cohen GB, Jung JU
  TITLE     Downregulation of major histocompatibility complex class I molecules by Kaposi's sarcoma-associated herpesvirus K3 and K5 proteins.
  JOURNAL   J Virol 74:5300-9 (2000)
            DOI:10.1128/JVI.74.11.5300-5309.2000
REFERENCE   PMID:17166914
  AUTHORS   Li Q, Means R, Lang S, Jung JU
  TITLE     Downregulation of gamma interferon receptor 1 by Kaposi's sarcoma-associated herpesvirus K3 and K5.
  JOURNAL   J Virol 81:2117-27 (2007)
            DOI:10.1128/JVI.01961-06
REFERENCE   PMID:18230726
  AUTHORS   Thomas M, Boname JM, Field S, Nejentsev S, Salio M, Cerundolo V, Wills M, Lehner PJ
  TITLE     Down-regulation of NKG2D and NKp80 ligands by Kaposi's sarcoma-associated herpesvirus K5 protects against NK cell cytotoxicity.
  JOURNAL   Proc Natl Acad Sci U S A 105:1656-61 (2008)
            DOI:10.1073/pnas.0707883105
REFERENCE   PMID:11413168
  AUTHORS   Coscoy L, Ganem D
  TITLE     A viral protein that selectively downregulates ICAM-1 and B7-2 and modulates T cell costimulation.
  JOURNAL   J Clin Invest 107:1599-606 (2001)
            DOI:10.1172/JCI12432
REFERENCE   PMID:24710493
  AUTHORS   Pratt ZL, Sugden B
  TITLE     How human tumor viruses make use of autophagy.
  JOURNAL   Cells 1:617-30 (2012)
            DOI:10.3390/cells1030617
REFERENCE   PMID:10354594
  AUTHORS   Schulz TF, Moore PS
  TITLE     Kaposi's sarcoma-associated herpesvirus: a new human tumor virus, but how?
  JOURNAL   Trends Microbiol 7:196-200 (1999)
            DOI:10.1016/S0966-842X(99)01495-X
REFERENCE   PMID:9594662
  AUTHORS   Moore PS, Chang Y
  TITLE     Antiviral activity of tumor-suppressor pathways: clues from molecular piracy by KSHV.
  JOURNAL   Trends Genet 14:144-50 (1998)
            DOI:10.1016/S0168-9525(98)01408-5
REFERENCE   PMID:12770701
  AUTHORS   Verma SC, Robertson ES
  TITLE     Molecular biology and pathogenesis of Kaposi sarcoma-associated herpesvirus.
  JOURNAL   FEMS Microbiol Lett 222:155-63 (2003)
            DOI:10.1016/S0378-1097(03)00261-1
REFERENCE   PMID:11960692
  AUTHORS   Jenner RG, Boshoff C
  TITLE     The molecular pathology of Kaposi's sarcoma-associated herpesvirus.
  JOURNAL   Biochim Biophys Acta 1602:1-22 (2002)
            DOI:10.1016/S0304-419X(01)00040-3
REFERENCE   PMID:15220441
  AUTHORS   Foster-Cuevas M, Wright GJ, Puklavec MJ, Brown MH, Barclay AN
  TITLE     Human herpesvirus 8 K14 protein mimics CD200 in down-regulating macrophage activation through CD200 receptor.
  JOURNAL   J Virol 78:7667-76 (2004)
            DOI:10.1128/JVI.78.14.7667-7676.2004
REFERENCE   PMID:10987301
  AUTHORS   Sodhi A, Montaner S, Patel V, Zohar M, Bais C, Mesri EA, Gutkind JS
  TITLE     The Kaposi's sarcoma-associated herpes virus G protein-coupled receptor up-regulates vascular endothelial growth factor expression and secretion through mitogen-activated protein kinase and p38 pathways acting on hypoxia-inducible factor 1alpha.
  JOURNAL   Cancer Res 60:4873-80 (2000)
REFERENCE   PMID:27518127
  AUTHORS   Abere B, Schulz TF
  TITLE     KSHV non-structural membrane proteins involved in the activation of intracellular signaling pathways and the pathogenesis of Kaposi's sarcoma.
  JOURNAL   Curr Opin Virol 20:11-19 (2016)
            DOI:10.1016/j.coviro.2016.07.008
REFERENCE   PMID:15573137
  AUTHORS   Sodhi A, Montaner S, Gutkind JS
  TITLE     Viral hijacking of G-protein-coupled-receptor signalling networks.
  JOURNAL   Nat Rev Mol Cell Biol 5:998-1012 (2004)
            DOI:10.1038/nrm1529
REFERENCE   PMID:17329974
  AUTHORS   Montaner S
  TITLE     Akt/TSC/mTOR activation by the KSHV G protein-coupled receptor: emerging insights into the molecular oncogenesis and treatment of Kaposi's sarcoma.
  JOURNAL   Cell Cycle 6:438-43 (2007)
            DOI:10.4161/cc.6.4.3843
REFERENCE   PMID:23028325
  AUTHORS   Bala K, Bosco R, Gramolelli S, Haas DA, Kati S, Pietrek M, Havemeier A, Yakushko Y, Singh VV, Dittrich-Breiholz O, Kracht M, Schulz TF
  TITLE     Kaposi's sarcoma herpesvirus K15 protein contributes to virus-induced angiogenesis by recruiting PLCgamma1 and activating NFAT1-dependent RCAN1 expression.
  JOURNAL   PLoS Pathog 8:e1002927 (2012)
            DOI:10.1371/journal.ppat.1002927
REFERENCE   PMID:10318948
  AUTHORS   Lagunoff M, Majeti R, Weiss A, Ganem D
  TITLE     Deregulated signal transduction by the K1 gene product of Kaposi's sarcoma-associated herpesvirus.
  JOURNAL   Proc Natl Acad Sci U S A 96:5704-9 (1999)
            DOI:10.1073/pnas.96.10.5704
REFERENCE   PMID:26192396
  AUTHORS   Sousa-Squiavinato AC, Silvestre RN, Elgui De Oliveira D
  TITLE     Biology and oncogenicity of the Kaposi sarcoma herpesvirus K1 protein.
  JOURNAL   Rev Med Virol 25:273-85 (2015)
            DOI:10.1002/rmv.1843
REFERENCE   PMID:25187543
  AUTHORS   Havemeier A, Gramolelli S, Pietrek M, Jochmann R, Sturzl M, Schulz TF
  TITLE     Activation of NF-kappaB by the Kaposi's sarcoma-associated herpesvirus K15 protein involves recruitment of the NF-kappaB-inducing kinase, IkappaB kinases, and phosphorylation of p65.
  JOURNAL   J Virol 88:13161-72 (2014)
            DOI:10.1128/JVI.01766-14
REFERENCE   PMID:17050609
  AUTHORS   Brinkmann MM, Pietrek M, Dittrich-Breiholz O, Kracht M, Schulz TF
  TITLE     Modulation of host gene expression by the K15 protein of Kaposi's sarcoma-associated herpesvirus.
  JOURNAL   J Virol 81:42-58 (2007)
            DOI:10.1128/JVI.00648-06
REFERENCE   PMID:16585191
  AUTHORS   Wang L, Dittmer DP, Tomlinson CC, Fakhari FD, Damania B
  TITLE     Immortalization of primary endothelial cells by the K1 protein of Kaposi's sarcoma-associated herpesvirus.
  JOURNAL   Cancer Res 66:3658-66 (2006)
            DOI:10.1158/0008-5472.CAN-05-3680
REFERENCE   PMID:22521915
  AUTHORS   Morris VA, Punjabi AS, Wells RC, Wittkopp CJ, Vart R, Lagunoff M
  TITLE     The KSHV viral IL-6 homolog is sufficient to induce blood to lymphatic endothelial cell differentiation.
  JOURNAL   Virology 428:112-20 (2012)
            DOI:10.1016/j.virol.2012.03.013
REFERENCE   PMID:25594835
  AUTHORS   Purushothaman P, Uppal T, Verma SC
  TITLE     Molecular biology of KSHV lytic reactivation.
  JOURNAL   Viruses 7:116-53 (2015)
            DOI:10.3390/v7010116
REFERENCE   PMID:14991150
  AUTHORS   Fujimuro M, Hayward SD
  TITLE     Manipulation of glycogen-synthase kinase-3 activity in KSHV-associated cancers.
  JOURNAL   J Mol Med (Berl) 82:223-31 (2004)
            DOI:10.1007/s00109-003-0519-7
REFERENCE   PMID:26870016
  AUTHORS   Purushothaman P, Dabral P, Gupta N, Sarkar R, Verma SC
  TITLE     KSHV Genome Replication and Maintenance.
  JOURNAL   Front Microbiol 7:54 (2016)
            DOI:10.3389/fmicb.2016.00054
REL_PATHWAY hsa04010  MAPK signaling pathway
            hsa04064  NF-kappa B signaling pathway
            hsa04110  Cell cycle
            hsa04115  p53 signaling pathway
            hsa04140  Autophagy - animal
            hsa04144  Endocytosis
            hsa04151  PI3K-Akt signaling pathway
            hsa04210  Apoptosis
            hsa04310  Wnt signaling pathway
            hsa04610  Complement and coagulation cascades
            hsa04620  Toll-like receptor signaling pathway
            hsa04630  JAK-STAT signaling pathway
            hsa04650  Natural killer cell mediated cytotoxicity
            hsa04668  TNF signaling pathway
KO_PATHWAY  ko05167
///
